BridgeMD
Compares treatment options for Bronchopulmonary Dysplasia
Official title Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia
ClinicalTrials.gov ID: NCT06954142
What this study is testing
- What it's testing
- The aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infants born \<30 weeks gestational age.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 and older
You may be able to join if
- Hospitalised preterm infants born before 30 weeks 0 days gestation
- Signed informed consent for further research use of health-related data
You likely can't join if
- congenital malformations
- diseases likely to affect life expectancy, lung function, fluid strategy, or neurodevelopment
- renal disease requiring fluid management outside the clinical standard of care
- congenital heart disease not including patent ductus arteriosus (PDA)
The study team makes the final eligibility decision.
Where it's taking place
- Aarau, Switzerland
- Basel, Switzerland
- Bern, Switzerland
- Chur, Switzerland
- Geneva, Switzerland
- Lausanne, Switzerland
- Lucerne, Switzerland
- Sankt Gallen, Switzerland
- Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 days and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarau, Switzerland; Basel, Switzerland; Bern, Switzerland; Chur, Switzerland; Geneva, Switzerland; Lausanne, Switzerland and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.